Overview

Paracetamol in Patent Ductus Arteriosus

Status:
Completed

Trial end date:
2019-04-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to assess the efficacy and safety of paracetamol in comparison to ibuprofen in the treatment of patent ductus arteriosus (PDA) in preterm infants.

Phase:

Phase 2

Details

Lead Sponsor:

Aziende Chimiche Riunite Angelini Francesco S.p.A

Treatments:

Acetaminophen
Ibuprofen